Among 1209 LT recipients, 76 (6.3%) developed VRE infection, most commonly intra-abdominal (58.4%). Time-updated post-LT VRE colonization was the strongest predictor (HR 7.59). Additional risk factors included intraoperative bleeding (HR 4.06), early re-transplantation (HR 3.85), pre-LT VRE colonization (HR 3.20), renal replacement therapy (HR 2.01), and intensive care unit length of stay (HR 1.01/day). Viral hepatitis (HR 0.55), autoimmune hepatitis (HR 0.34), higher Charlson Comorbidity Index (HR 0.84), and deceased donors (HR 0.24) were associated with a lower risk of VRE infection. The final model showed good discrimination (AUROC = 0.76-0.85) with balanced sensitivity (75%-93%) and specificity (75%-86%).
Nunes et al. (Fri,) studied this question.